185 related articles for article (PubMed ID: 12118499)
1. The prevalence of prostate cancer screening in Thai elderly.
Tantiwong A; Soontrapa S; Sujijantrarat P; Vanprapar N; Sawangsak L
J Med Assoc Thai; 2002 Apr; 85(4):502-8. PubMed ID: 12118499
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
3. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; Roemeling S; Schröder FH
Eur Urol; 2008 Sep; 54(3):581-8. PubMed ID: 18423977
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
[TBL] [Abstract][Full Text] [Related]
5. [Results of a screening program for prostatic cancer].
Martín Oses E; Luján Galán M; Sánchez Sánchez E; Herrero Payo A; Páez Borda A; Berenguer Sánchez A
Actas Urol Esp; 1999 Apr; 23(4):287-95. PubMed ID: 10394648
[TBL] [Abstract][Full Text] [Related]
6. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
7. Histological diagnosis of prostate cancer in Korean men aged 70-79 years.
Shim HB; Lee SE; Park HK; Ku JH
Jpn J Clin Oncol; 2007 Oct; 37(10):782-7. PubMed ID: 17913831
[TBL] [Abstract][Full Text] [Related]
8. The value of prostatic specific antigen in prostate cancer screening in the community.
Jubelirer SJ; Tierney JP; Oliver S; Serrato JM; Farra S; Plymale J; Hodge E
W V Med J; 1994 Apr; 90(4):140-2. PubMed ID: 7516602
[TBL] [Abstract][Full Text] [Related]
9. Digital rectal examination is barrier to population-based prostate cancer screening.
Nagler HM; Gerber EW; Homel P; Wagner JR; Norton J; Lebovitch S; Phillips JL
Urology; 2005 Jun; 65(6):1137-40. PubMed ID: 15922431
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, management and screening of early localised prostate cancer.
Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
[TBL] [Abstract][Full Text] [Related]
11. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK
Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
[TBL] [Abstract][Full Text] [Related]
12. Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer.
Galić J; Karner I; Cenan L; Tucak A; Hegedus I; Pasini J; Bilandzija-Peranović M; Mihaljević S
Coll Antropol; 2003; 27 Suppl 1():61-6. PubMed ID: 12955893
[TBL] [Abstract][Full Text] [Related]
13. Digital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer.
Shim HB; Lee SE; Park HK; Ku JH
Prostate Cancer Prostatic Dis; 2007; 10(3):250-5. PubMed ID: 17297501
[TBL] [Abstract][Full Text] [Related]
14. Self-reported prostate cancer screening in Austria.
Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G
J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.
Bunker CH; Patrick AL; Konety BR; Dhir R; Brufsky AM; Vivas CA; Becich MJ; Trump DL; Kuller LH
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):726-9. PubMed ID: 12163325
[TBL] [Abstract][Full Text] [Related]
16. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination.
Leewansangtong S; Tantiwong A; Ratanarapee S; Nualyong C; Soontrapa S
J Med Assoc Thai; 2000 Dec; 83(12):1519-24. PubMed ID: 11253893
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of prostate cancer detected by digital rectal examination only.
Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ
Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
19. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.
Eggener SE; Roehl KA; Catalona WJ
J Urol; 2005 Aug; 174(2):500-4. PubMed ID: 16006880
[TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]